昊帆生物
(301393)
| 流通市值：24.77亿 | | | 总市值：63.53亿 |
| 流通股本：4210.48万 | | | 总股本：1.08亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 534,555,682.4 | 408,664,617 | 614,999,722.33 | 974,047,893.62 |
| 交易性金融资产 | 829,872,558.38 | 902,018,402.66 | 878,622,079.09 | 725,234,474.32 |
| 应收票据及应收账款 | 179,821,143.8 | 183,646,280.5 | 163,371,396.38 | 131,286,092.69 |
| 其中：应收票据 | 9,265,703.74 | 25,277,696.67 | 20,446,551.64 | 15,907,560.17 |
| 应收账款 | 170,555,440.06 | 158,368,583.83 | 142,924,844.74 | 115,378,532.52 |
| 应收款项融资 | 2,562,803.01 | 5,614,581 | 1,256,426.51 | 1,306,932 |
| 预付款项 | 12,271,487.29 | 4,261,923.98 | 8,449,954.15 | 2,940,572.61 |
| 其他应收款合计 | 1,235,813.47 | 1,191,077.91 | 1,577,875.91 | 1,331,585.84 |
| 存货 | 165,838,117.44 | 161,183,690.92 | 156,003,577.61 | 137,768,391.28 |
| 其他流动资产 | 33,567,700.93 | 23,418,377.31 | 11,614,653.82 | 9,789,313.4 |
| 流动资产合计 | 1,759,725,306.72 | 1,689,998,951.28 | 1,835,895,685.8 | 1,983,705,255.76 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 123,238,253.42 | 122,602,089.04 | - | - |
| 固定资产 | 402,395,195.99 | 411,891,818.5 | 422,196,889.91 | 284,958,329.05 |
| 在建工程 | 315,998,466.99 | 217,389,234.8 | 94,880,250.75 | 68,968,461.45 |
| 使用权资产 | 1,695,180.2 | 2,143,552.52 | 2,591,924.84 | 3,040,297.16 |
| 无形资产 | 106,706,719.42 | 105,425,107.3 | 95,149,229.42 | 65,654,866.93 |
| 商誉 | 57,853,593.52 | 57,853,593.52 | 71,721,165.16 | - |
| 长期待摊费用 | 322,898.8 | 350,671 | 505,465.99 | 67,187.84 |
| 递延所得税资产 | 11,515,857.93 | 11,990,139.62 | 11,724,218.64 | 4,790,799.89 |
| 其他非流动资产 | 32,952,515 | 34,764,703.91 | 15,125,224.34 | 8,745,226.34 |
| 非流动资产合计 | 1,052,678,681.27 | 964,410,910.21 | 713,894,369.05 | 436,225,168.66 |
| 资产总计 | 2,812,403,987.99 | 2,654,409,861.49 | 2,549,790,054.85 | 2,419,930,424.42 |
| 流动负债: | | | | |
| 短期借款 | 10,011,030.56 | 10,011,030.56 | 10,211,250 | - |
| 应付票据及应付账款 | 265,070,393.04 | 152,305,833.57 | 84,376,165.47 | 53,488,224.67 |
| 其中：应付票据 | 172,932,264.8 | 40,984,687 | 26,374,160 | 19,768,470 |
| 应付账款 | 92,138,128.24 | 111,321,146.57 | 58,002,005.47 | 33,719,754.67 |
| 合同负债 | 1,900,020.58 | 782,474.03 | 785,944.49 | 516,690.88 |
| 应付职工薪酬 | 10,313,932.35 | 19,617,571.57 | 17,330,610.59 | 10,382,112.95 |
| 应交税费 | 7,206,354.02 | 8,362,907.96 | 10,200,954.55 | 7,401,482.03 |
| 其他应付款合计 | 22,598,845.35 | 23,650,514.94 | 41,603,250.81 | 920,749.65 |
| 一年内到期的非流动负债 | 1,167,050.5 | 1,409,434.46 | 1,378,632.58 | 1,960,062.25 |
| 其他流动负债 | 7,003,447.46 | 22,729,166.19 | 16,000,031.6 | 15,422,962.85 |
| 流动负债合计 | 325,271,073.86 | 238,868,933.28 | 181,886,840.09 | 90,092,285.28 |
| 非流动负债: | | | | |
| 长期借款 | 76,175,119.6 | 39,467,052.4 | - | - |
| 租赁负债 | 448,085.11 | 444,353.25 | 760,108.57 | 881,335.8 |
| 递延收益 | 8,874,913.02 | 9,220,112.46 | 9,565,311.94 | 9,449,641.69 |
| 递延所得税负债 | 7,104,470.84 | 7,235,816.82 | 8,151,613.37 | 660,591.4 |
| 非流动负债合计 | 92,602,588.57 | 56,367,334.93 | 18,477,033.88 | 10,991,568.89 |
| 负债合计 | 417,873,662.43 | 295,236,268.21 | 200,363,873.97 | 101,083,854.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 1,691,767,889.57 | 1,689,936,118.66 | 1,688,008,841.09 | 1,689,819,423.48 |
| 减:库存股 | 33,421,938.39 | 33,421,938.39 | 33,421,938.39 | 42,000,590.49 |
| 其他综合收益 | 183,087.06 | 106,026.85 | 132,740.77 | 142,913.01 |
| 专项储备 | 5,524,814.45 | 4,840,115.17 | 4,262,119.58 | 3,793,952.35 |
| 盈余公积 | 54,000,000 | 54,000,000 | 54,867,446.69 | 53,432,250.22 |
| 未分配利润 | 562,831,937.64 | 529,387,239.08 | 527,576,971.14 | 505,658,621.68 |
| 归属于母公司股东权益合计 | 2,388,885,790.33 | 2,352,847,561.37 | 2,349,426,180.88 | 2,318,846,570.25 |
| 少数股东权益 | 5,644,535.23 | 6,326,031.91 | - | - |
| 股东权益合计 | 2,394,530,325.56 | 2,359,173,593.28 | 2,349,426,180.88 | 2,318,846,570.25 |
| 负债和股东权益合计 | 2,812,403,987.99 | 2,654,409,861.49 | 2,549,790,054.85 | 2,419,930,424.42 |
| 公告日期 | 2026-04-24 | 2026-04-17 | 2025-10-29 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |